Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC (R)-GSK-3685032 | 2170140-50-6 | 99.0% | 420.53 g·mol⁻¹ | C22H24N6OS | 5 MG
SDP

Catalog No. 5000221304
Encompass_Preferred

(R)-GSK-3685032 is the R-enantiomer of GSK-3685032, a reversible, DNMT1-selective inhibitor used in epigenetics research to induce loss of DNA methylation, transcriptional activation, and cancer cell growth inhibition. The compound is characterized by a defined molecular formula and high reported purity, and it is supplied for in vitro and preclinical research use.

  • Reversible DNMT1-selective inhibitor with reported low-nanomolar activity.
  • Induces loss of DNA methylation and downstream transcriptional activation.
  • High reported purity and fully characterized molecular properties.
  • Available in small, research-scale pack sizes for preclinical studies.

Catalog No. 50-002-21304 Supplier Medchemexpress LLC Supplier No. HY139664A5MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

(R)-GSK-3685032 is the R-enantiomer of GSK-3685032, a reversible, DNMT1-selective inhibitor used in epigenetics research to induce loss of DNA methylation, transcriptional activation, and cancer cell growth inhibition. The compound is characterized by a defined molecular formula and high reported purity, and it is supplied for in vitro and preclinical research use.

  • Reversible DNMT1-selective inhibitor with reported low-nanomolar activity.
  • Induces loss of DNA methylation and downstream transcriptional activation.
  • High reported purity and fully characterized molecular properties.
  • Available in small, research-scale pack sizes for preclinical studies.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.